ASBPW

Aspire Biopharma Warrant
ASBPW

30 hedge funds and large institutions have $604K invested in Aspire Biopharma Warrant in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $
Holders
30
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$798K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$8.33K
2
+$4.07K
3
+$2.38K
4
CAC
Cowen and Company
New York
+$1.37K
5
HF
HRT Financial
New York
+$675

Top Sellers

1
-$12.5K
2
-$5.95K
3
-$5.1K
4
KL
KIM LLC
Kansas
-$4.49K
5
EAM
Exos Asset Management
New York
-$4.11K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$261K
2
$72K
3
$41.6K
4
$34K
5
$27.4K
6
$23.5K
7
$18.9K
8
$18.3K
9
$17K
10
$15K
11
$12.7K
12
$8.46K
13
$7.4K
14
$6.3K
15
$5.86K
16
$5.86K
17
$5.29K
18
$4.48K
19
$4.23K
20
$3.17K
21
$2K
22
$1.97K
23
$1.21K
24
$1.11K
25
$1.06K
1
2